Simone Eli is a sports anchor and co-host of New York Nightcap, airing weekdays at 11 p.m. on PIX11. Recognized as one of Nexstar Media Group’s top sports anchors, Simone plays a key role in leading ...

It took 22 years, but Eli Manning has finally revealed the details behind one of the biggest draft controversies in NFL history. Back in 2004, the Chargers made Manning the No. 1 overall pick in the ...

While the new Canyon Endurace CFR grabbed headlines with its pro geometry and wind-tunnel optimised design when it was released in April, the lack of options beneath the highest level meant it was ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Perhaps the most compelling moment of the 2026 NFL Draft came in the final round, when the Pittsburgh Steelers selected running back Eli Heidenreich and the pick was announced to the hometown crowd ...

Eli Heidenreich will begin his NFL career at home. The Navy football standout was drafted on Day 3 in the seventh round of the 2026 NFL Draft by the hometown Pittsburgh Steelers. He was selected as ...

Eli Lilly struck a deal to acquire Kelonia Therapeutics for $3.25 billion, the companies said Monday. The deal price could reach as much as $7 billion if Kelonia reaches certain clinical, regulatory ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Eli Lilly currently leads the rapidly growing weight-loss market. The company's tirzepatide, sold under the brand name Zepbound, is now the world's best-selling drug. Over the next two years, the ...

Eli Lilly (NYSE: LLY) and Vertex Pharmaceuticals (NASDAQ: VRTX) have several things in common. Both are among the more prominent drugmakers in the world, and both have delivered market-beating returns ...